PAP
PRTC

Persistent Asset Partners’s PureTech Health PRTC Stock Holding History

Persistent Asset Partners’s Portfolio PRTC Stock Details PRTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.1K Hold
1,759
– – 0.01% 275
2025
Q4 		$29.4K Buy
1,759
+74
+4% +$1.27K 0.01% 307
2025
Q3 		$31.2K Hold
1,685
– – 0.02% 195
2025
Q2 		$29.1K Buy
+1,685
New +$29.7K 0.02% 159

Other funds holding PRTC

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Persistent Asset Partners's PRTC Position: Q1 2026 in Review

Persistent Asset Partners held its PureTech Health (PRTC) position steady in Q1 2026 at 1,759 shares worth $26.1K. The position accounts for 0.01% of the portfolio, ranked #275.

Persistent Asset Partners first reported a position in PRTC in Q2 2025 and has held it in 4 quarters since. The position peaked at $31.2K in Q3 2025. 5 funds tracked by Wall St. Rank hold PRTC as of Q1 2026.

  • Persistent Asset Partners held 1,759 shares of PureTech Health worth $26.1K as of Q1 2026.
  • Persistent Asset Partners left its PureTech Health share count unchanged in Q1 2026.
  • PureTech Health made up 0.01% of Persistent Asset Partners's portfolio in Q1 2026, its #275 holding.
  • Persistent Asset Partners first reported a position in PureTech Health in Q2 2025 and has held it in 4 quarters since.
  • Persistent Asset Partners's PureTech Health position peaked at $31.2K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held PureTech Health as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.